> Products > 137234-62-9

China 137234-62-9 Factory

keep on to improve, to make sure solution good quality in line with market and shopper standard requirements. Our business has a top quality assurance program are actually established for 137234-62-9,CAS NO 137234-62-9,Voriconazole film-coated Tablets,Voriconazole Tablets,Voriconazole formulation, We welcome new and aged consumers to speak to us by telephone or send out us inquiries by mail for long term company associations and attaining mutual results.
137234-62-9, Our mission is "Provide Products and solutions with Reliable Quality and Reasonable Prices". We welcome customers from every corner of the world to contact us for future business relationships and achieving mutual success!

Hot Products

N-((3R,4R)-1-Benzyl-4-methylpiperidin-3-yl)-N-methyl-7-tosyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine
Product Name:N-((3R,4R)-1-Benzyl-4-methylpiperidin-3-yl)-N-methyl-7-tosyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine
Molecular Formula:C27H31N5O2S
Molecular Weight:489.63
CAS Registry Number:923036-30-0
DMT-2'O-Methyl-rU Phosphoramidite
Product Name:DMT-2'O-Methyl-rU Phosphoramidite
Molecular Formula:C40H49N4O9P
Molecular Weight:760.82
CAS Registry Number:110764-79-9
5-Formamide-1-(2-formyloxyethl)pyrazole
Product Name:5-Formamide-1-(2-formyloxyethl)pyrazole
Molecular Formula:C7H9N3O3
Molecular Weight:183.16
CAS Registry Number:116856-18-9
(R)-(+)-1-Phenylethanol
Product Name:(R)-(+)-1-Phenylethanol
Molecular Formula:C8H10O
Molecular Weight:122.16
CAS Registry Number:1517-69-7
Citicoline sodium
Product Name:Citicoline sodium
Molecular Formula:C14H27N4NaO11P2
Molecular Weight;512.32
CAS Registry Number;33818-15-4
(4aS,9bR)-Ethyl 6-bromo-5-(2-(methylamino)-2-oxoethyl)-3,4,4a,5-tetrahydro-1H-pyrido[4,3-b]indole-2(9bH)-carboxylate
Product Name:(4aS,9bR)-Ethyl 6-bromo-5-(2-(methylamino)-2-oxoethyl)-3,4,4a,5-tetrahydro-1H-pyrido[4,3-b]indole-2(9bH)-carboxylate
Molecular Formula:C17H22BrN3O3
Molecular Weight:396.28
CAS Registry Number:2098497-32-4

Related Blog
Reviews

Outsourcing of API Manufacturing – Are Strict Regulation and Quality Checks Necessary?
Here are so many diseases that affect the human population in the current hours and so are the numerous drugs that are available to treat those diseases.
Caffeine CAS No.58-08-2
Caffeine (CAS No.58-08-2) is a xanthine alkaloid compound, a central nervous stimulant that temporarily drives away drowsiness and restores energy, and is used clinically to treat neurosis and coma recovery. Caffeinated coffee, tea, soft drinks and energy drinks are very popular, so caffeine is also the most commonly used psychotropic drug in the world.
Development Trend of China's Pharmaceutical Intermediate Industry
The rapid development of China's pharmaceutical intermediate industry is closely related to its national policies. Since 2016, China has issued clear documents to encourage small and medium-sized enterprises to develop new drugs, including chemical raw materials. At the same time, the structural upgrading of the pharmaceutical industry in developed countries has promoted the transfer of global related industrial chains and promoted China's chemical raw material drug supply chain. In addition, the increase in Chinese radiography technology has boosted product demand.
How to find the best China API manufacturer?
Active pharmaceutical ingredients or APIs can be defined as the chemicals used to manufacture pharmaceutical drugs. The active ingredient (AI) is the substance or substances that are biologically active within the drug and is the specific component responsible for the desired effect it has on the individual taking it.
Everything You Need To Know About Active Pharmaceutical Ingredients (API In Pharma)
Sandoo, as a professional API manufactruer in China, we produces a wide range of active pharmaceutical ingredients which can be used in the production of medicines in different applications. Our products are produced under strict procedures and cGMP (Current Good Manufacturing Practices). In addtion, we can also customize new pharmaceutical compounds for new drugs.
FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC
On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

Related Search

CAS NO 137234-62-9 CAS NO:137234-62-9

China 137234-62-9 Factory

Related Products

Hot Products

N-((3R,4R)-1-Benzyl-4-methylpiperidin-3-yl)-N-methyl-7-tosyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine

DMT-2'O-Methyl-rU Phosphoramidite

5-Formamide-1-(2-formyloxyethl)pyrazole

(R)-(+)-1-Phenylethanol

Citicoline sodium

(4aS,9bR)-Ethyl 6-bromo-5-(2-(methylamino)-2-oxoethyl)-3,4,4a,5-tetrahydro-1H-pyrido[4,3-b]indole-2(9bH)-carboxylate

Outsourcing of API Manufacturing – Are Strict Regulation and Quality Checks Necessary?

Caffeine CAS No.58-08-2

Development Trend of China's Pharmaceutical Intermediate Industry

How to find the best China API manufacturer?

Everything You Need To Know About Active Pharmaceutical Ingredients (API In Pharma)

FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

David 2022-08-26 15:46:27

Adam 2023-03-20 00:04:26

Patricia 2023-10-30 12:02:08

Judy 2023-01-27 16:07:18

Miranda 2023-09-19 05:00:15

Rosemary 2023-10-13 17:01:43

Related Search

Send Inquiry